本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

AVECHO BIOTECHNOLOGY LTD

0.004
0.000
成交量:610.11万
成交额:2.44万
市值:1,269.39万
市盈率:-4.00
高:0.004
开:0.004
低:0.004
收:0.004
数据加载中...

公司资料

公司名字:
AVECHO BIOTECHNOLOGY LTD
交易所:
ASX
成立时间:
1992
员工人数:
15
公司地址:
Hallmarc Business Park,Unit A8,2A Westall Road,Clayton,Victoria,Australia
邮编:
3168
传真:
61 3 9002 5000
简介:
Avecho Biotechnology Limited, a biotechnology company, develops, produces, sells, and licenses products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, skin care, animal health, and nutrition industries. The company operates through Production, Human Health, and Animal Health and Nutrition segments. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company serves customers in Australia, Switzerland, the United States, India, Japan, China, Singapore, and internationally. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited is based in Melbourne, Australia.